Rezultati - Michèle Cavo

Refine Results
  1. 1
    Imaging in multiple myeloma: How? When?

    Imaging in multiple myeloma: How? When? od Elena Zamagni, Paola Tacchetti, Michèle Cavo

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update

    Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update od Luana Bavaro, Maurizio Martelli, Michèle Cavo, Simona Soverini

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Staging of chronic lymphocytic leukemia

    Staging of chronic lymphocytic leukemia od Michele Baccarani, Michèle Cavo, Marco Gobbi, F. Lauria, S Tura

    Izdano 1982
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

    Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy od Simona Soverini, Manuela Mancini, Luana Bavaro, Michèle Cavo, Giovanni Martinelli

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years

    Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years od Francesca Palandri, Nicola Polverelli, Daria Sollazzo, Marco Romano, Lucia Catani, Michèle Cavo, Nicola Vianelli

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    PGE<sub>2</sub>-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an<i>In Vitro</i>Antileukemic Immune Response

    PGE<sub>2</sub>-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an<i>In Vitro</i>Antileukemic Immune Response od Sara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, Michèle Cavo, Darina Očadlíková, Roberto M. Lemoli, Antonio Curti

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche

    Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche od Antonio Giovanni Solimando, Eleonora Malerba, Patrizia Leone, Marcella Prete, Carolina Terragna, Michèle Cavo, Vito Racanelli

    Izdano 2022
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia

    The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia od Marilena Ciciarello, Giulia Corradi, Federica Loscocco, Giuseppe Visani, Federica Monaco, Michèle Cavo, Antonio Curti, Alessandro Isidori

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation

    Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation od Francesca Bonifazi, Francesco Barbato, Federico Ravaioli, Mariarosaria Sessa, Irene Defrancesco, Mario Arpinati, Michèle Cavo, Antonio Colecchia

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling

    The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling od Dorian Forte, Valentina Salvestrini, Giulia Corradi, Lara Rossi, Lucia Catani, Roberto M. Lemoli, Michèle Cavo, Antonio Curti

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients

    Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients od Valentina Salvestrini, Gabriele Conti, Federica D’Amico, Gianluca Cristiano, Marco Candela, Michèle Cavo, Silvia Turroni, Antonio Curti

    Izdano 2025
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.

    Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. od Gösta Gahrton, S Tura, Per Ljungman, Joan Bladé, Lena Brandt, Michèle Cavo, Thierry Façon, Aloïs Gratwohl, Anton Hagenbeek, Peter Jacob

    Izdano 1995
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Proteasome inhibitors in multiple myeloma: 10 years later

    Proteasome inhibitors in multiple myeloma: 10 years later od Philippe Moreau, Paul G. Richardson, Michèle Cavo, Robert Z. Orlowski, Jesús F. San Miguel, Antonio Palumbo, Jean‐Luc Harousseau

    Izdano 2012
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival

    Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell su... od Giulia Corradi, Carmen Baldazzi, Darina Očadlíková, Giovanni Marconi, Sarah Parisi, Nicoletta Testoni, Carlo Finelli, Michèle Cavo, Antonio Curti, Marilena Ciciarello

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

    Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy od Michèle Cavo, Elena Zamagni, Claudia Cellini, Patrizia Tosi, Delia Cangini, Michela Cini, Lelia Valdré, Gualtiero Palareti, Luciano Masini, S Tura, Michele Baccarani

    Izdano 2002
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Solitary plasmacytoma of bone and extramedullary plasmacytoma: Two different entities?

    Solitary plasmacytoma of bone and extramedullary plasmacytoma: Two different entities? od Piero Galieni, Michèle Cavo, Giuseppe Avvisati, Alessandro Pulsoni, Rosanna Falbo, M. A. Bonelli, Domenico Russo, Maria Teresa Petrucci, Alessandro Bucalossi, S Tura

    Izdano 1995
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies

    A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies od Marta Stanzani, Russell E. Lewis, Mauro Fiacchini, Paolo F. Ricci, Fabio Tumietto, Pierluigi Viale, Simone Ambretti, Michele Baccarani, Michèle Cavo, Nicola Vianelli

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) with Standard of Care for Patients from Latin America with Newly Diagnosed Multiple Myeloma (NDMM) Who Were Transplant Ineligible: A Propensity Score Matching Analysis

    Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) with Standard of Care for Patients from Latin America with Newly Diagnosed Multiple Myeloma (NDMM) Who... od Vânia Hungria, Déborah Martı́nez-Baños, María‐Victoria Mateos, Meletios Α. Dimopoulos, Michèle Cavo, Bart Heeg, Annette Lam, Gerardo Machnicki, Jianming He, Mariana Fernandez

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an &lt;i&gt;ad hoc&lt;/i&gt; expert panel

    Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an &lt;i&gt;ad hoc&lt;/i&gt;... od Valerio De Stefano, Alessandra Larocca, Monica Carpenedo, Michèle Cavo, Francesco Di Raimondo, Anna Falanga, Massimo Offidani, Maria Teresa Petrucci, Marco Ruggeri, Roberto Santi, Giovanni Barosi

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells

    Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+... od Roberto M. Lemoli, Alessandra Fortuna, MR Motta, Simonetta Rizzi, Valentina Giudice, A Nannetti, Giovanni Martinelli, Michèle Cavo, Marilina Amabile, Serena Mangianti, M Fogli, Roberto Conte, S Tura

    Izdano 1996
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: